Autor: |
Zordok M; Department of Medicine, Catholic Medical Center, Manchester, NH, USA., Dani SS; Division of Cardiology, Lahey Medical Center, Burlington, MA, USA., Tawadros M; Department of Medicine, Baptist Health System, Little Rock, AR, USA., Lichaa HT; Division of Cardiac Sciences, Ascension Saint Thomas Rutherford, Murfreesboro, TN, USA., Kerrigan JL; Division of Cardiac Sciences, Ascension Saint Thomas Heart, Nashville, TN, USA., Basir B; Division of Cardiology, Henry Ford Hospital, Detroit, MI, USA., Alaswad K; Division of Cardiology, Henry Ford Hospital, Detroit, MI, USA., Miedema M; Nolan Family Center for Cardiovascular Health, Minneapolis Heart Institute Foundation, MN, USA., Megaly M; Department of Cardiology, Ascension St John Medical Institute, Tulsa, OK, USA. Electronic address: magdi.zordok@cmc-nh.org. |
Abstrakt: |
Competing Interests: Disclosure of interests Khaldoon Alaswad reports consulting/speaker honoraria from Boston Scientific, Cardiovascular Systems Inc, Abbott Vascular, and Teleflex. Hady Lichaa reports consulting/speaker honoraria from Abbott Vascular, Abiomed, Cordis, Philips, Penumbra, and Shockwave Medical. Mir Basir reports consulting/speaking for Abiomed, Boston Scientific, Chiesi, Saranas, and Zoll. Jimmy Kerrigan reports consulting/speaking for Abbott, Abiomed, Amgen, Asahi, Biotronik, Boston Scientific, Chiesi, Cordis, Heartflow, Ischemaview Inc, Kardion, Kiniksa, Medtronic, Merit, Osprey Medical, Philips, Siemens, Shockwave, and Teleflex. The remaining authors have no conflicts of interest to disclose. |